Short-term effect of antibiotic control policy on the usage patterns and cost of antimicrobials, mortality, nosocomial infection rates and antibacterial resistance

Journal of Infection

Volumn 55, Issue 1, 2007, Pages 41-48

  Arda, Bilgin ^a   Sipahi, Oguz Resat ^a   Yamazhan, Tansu ^a   Tasbakan, Meltem ^a   Pullukcu, Husnu ^a   Tunger, Alper ^a   Buke, Cagri ^a   Ulusoy, Sercan ^a  

^a EGE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Antibiotic control policy; Daily defined dose; DDD; Mortality; MRSA; Nosocomial infection rate; Resistance patterns; Turkiye; VRE

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; CEFAZOLIN; CEFEPIME; CEFOPERAZONE; CEFOTAXIME; CEFTAZIDIME; CEFTIZOXIME; CEFTRIAXONE; CEFUROXIME; CIPROFLOXACIN; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN; IMIPENEM; ISEPAMICIN; LEVOFLOXACIN; MEROPENEM; METICILLIN; NETILMICIN; OFLOXACIN; PIPERACILLIN PLUS TAZOBACTAM; SULBACTAM; SULPERAZON; SULTAMICILLIN; TEICOPLANIN; TICARCILLIN; UNINDEXED DRUG; VANCOMYCIN;

ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; ARTICLE; CONTROLLED STUDY; COST CONTROL; DRUG COST; DRUG USE; ESCHERICHIA COLI; HEALTH CARE POLICY; HOSPITAL INFECTION; HUMAN; INTENSIVE CARE UNIT; KLEBSIELLA PNEUMONIAE; MAJOR CLINICAL STUDY; MICROBIOLOGICAL EXAMINATION; MORTALITY; NONHUMAN;

ANTI-BACTERIAL AGENTS; BACTEREMIA; BACTERIAL INFECTIONS; CROSS INFECTION; DRUG RESISTANCE, MICROBIAL; DRUG UTILIZATION REVIEW; ECONOMICS, HOSPITAL; HEALTH POLICY; HUMANS; INTENSIVE CARE UNITS; SURVIVAL RATE; TIME FACTORS; TURKEY;

EID: 34250026407     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jinf.2007.02.014     Document Type: Article

References (38)

1. Etiler B.N., Saba R., Günseren F., and Mamikoǧlu L. Akdeniz Üniversite Hastanesi'nde uygunsuz antimikrobiyal ilaç kullani{dotless}mi{dotless}n doǧrudan maliyeti karşi{dotless}laşti{dotless}ri{dotless}lmasi{dotless}. Turk J Hosp Infect 4 (2000) 144-147
2. Tunger O., Dinc G., Ozbakkaloglu B., Atman U.C., and Algun O. Evaluation of rational antibiotic use. Int J Antimicrob Agents 15 (2000) 131-135
3. Buke C., Sipahi O.R., Tasbakan M., Yamazhan T., Arda B., Ozinel M.A., et al. The evaluation of the infections developing in intensive care unit of the internal medicine department. Turk J Infect 19 (2005) 67-73
4. Usluer G., Ozgunes I., and Leblebicioglu H. Turkish antibiotic utilization study group. A multicenter point-prevalence study: antimicrobial prescription frequencies in hospitalized patients in Turkey. Ann Clin Microbiol Antimicrob 4 (2005) 16
5. Marr J.J., Moffet H.L., and Kunin C.M. Guidelines for improving the use of antimicrobial agents in hospitals. A statement by the infectious diseases society of America. J Infect Dis 157 (1988) 869-874
6. Petrak M.R., Sexton D.J., Butera M.L., Tenenbaum M.J., MacGregor M.C., Schmidt M.E., et al. The value of an infectious diseases specialist. Clin Infect Dis 36 (2003) 1013-1017
7. Wilkins E.G.L., Hickey M.M., Khoo S., Hale A.D., Umasankar S., Thomas P., et al. Northwick park infection consultation service part II. Contribution of the service to patient management: an analysis of results between September 1987 and July 1990. J Infect 23 (1991) 57-63
8. Wilkins E.G.L., Hickey M.M., Khoo S., Hale A.D., Umasankar S., Thomsas P., et al. Northwick park infection consultation service part 1. The aims and operation of the service and the general distribution of infection identified by the service between September 1987 and July 1990. J Infect 23 (1991) 47-56
9. Hamzaoglu O, Kilic B. Türkiye Saǧli{dotless}k İstatistikleri Türk Tabipler Birliǧi Yayi{dotless}nlari{dotless} no:001; 2000.
10. Resmi Gazete (1 February, 2003) n:25.011
11. WHO Collaborating Centre for Drug Statistics Methodology. Anatomic Therapeutic Chemical (ATC) classification index with Defined Daily Doses (DDDs) (2003), WHO Collaborating Centre for Drug Statistics Methodology, Oslo, Norway. http://www.whocc.no/atcddd/ [accessed 05.05.04]
12. Garner J.S., Jarwis W.R., Emori T.G., Horan T.C., and Hughes J.M. CDC definitions for nosocomial infections. Am J Infect Control 16 (1988) 128
13. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial disc susceptibility tests. Approved Standard. M2-A6 (1997), NCCLS, Villanova, PA
14. Sturenburg E., and Mark D. Extended spectrum beta lactamases: implications for clinical microbiology, laboratory therapy and infection control. J Infect 47 (2003) 273-295
15. Mandell A.L., Bartlett J.G., Dowell S.F., File M.T., Musher D.M., and Whitney C. Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults. Clin Infect Dis 37 (2003) 1406-1433
16. Akan H., Akan O.A., Akova M., Arikan S., Arslan H., Aydin K., et al. Guidelines for diagnosis and treatment of neutropenic patients. Flora 9 (2004) 5-28
17. Gould F.K., Elliott T.S., Foweraker J., Fulford M., Perry J.D., Roberts G.J., et al. Guidelines for the antibiotic treatment of endocarditis in adults: report of the working party of the British society for antimicrobial chemotherapy. J Antimicrob Chemother 54 (2004) 971-981
18. Ozinel M.A., Baki{dotless}r M., Cek M., Zorlu F., Guven M., and Bozfakioglu S. Üriner sistem infeksiyonlari{dotless}ni{dotless}n önlenmesi ki{dotless}lavuzu. Turk J Hosp Infect 8 Suppl. 1 (2004) 1-12
19. Ege Üniversitesi Ti{dotless}p Fakültesi, Mikrobiyoloji ve Klinik Mikrobiyoloji Anabilim Dali{dotless}. Kliniklere göre soyutlanan bakteriler ve antibiyotik duyarli{dotless}li{dotless}k sonuçlari{dotless}. 1996. Ege Üniversitesi Ti{dotless}p Fakültesi Yayi{dotless}nlari{dotless}.
20. White C.A., Atmar R.L., Wilson J., Cate T.R., Stager C.E., and Greenberg S.B. Effects of prior authorization for selected antimicrobials: expenditures, susceptibilities and clinical outcomes. Clin Infect Dis 25 (1997) 230-239
21. McGowan Jr. J.E., and Finland M. Usage of antibiotics in a general hospital effect of requiring justification. J Infect Dis 130 (1974) 165-168
22. Kunin C.M. The responsibility of the infectious diseases community for the optimal use of antimicrobial agents. J Infect Dis 151 (1985) 388-398
23. Erbay A., Bodur H., Akinci E., and Colpan A. Evaluation of antibiotic use in intensive care units of a tertiary care hospital in Turkey. J Hosp Infect 59 (2005) 53-61
24. Hirscman S.Z., Meyers B.R., Bradbury K., Mehl B., Gendelman S., and Kimelblatt B. Use of antimicrobial agents in a university teaching hospital. Evolution of a comprehensive control program. Arch Intern Med 148 (1988) 2001-2007
25. Wilton P., Smith R., Coast J., and Millar M. Strategies to contain the emergence of antimicrobial resistance: a systematic review of effectiveness and cost effectiveness. J Health Serv Res Policy 7 (2002) 111-116
26. Kilic S., Besirbellioglu B.A., Yagci A., Pahsa A., Doganci L., and Pekcan M. GATA'da antibiyotik kullani{dotless}mi{dotless}ni{dotless} kontrol uygulamalari{dotless}ni{dotless}n dört yi{dotless}lli{dotless}k mali sonuçlari{dotless} [abstract p19]. In: Proceedings of hastane infeksiyonlari{dotless} kongresi, Hastane İnfeksiyonlari{dotless} Derneǧi, Ankara, 2004. Turk J Hosp Infec 8 Suppl. 2 (2004) 12
27. Bassetti M., Biagio A.D., Rebesco B., Cenderello G., Amalfitano M.E., and Bassetti D. Impact of an antimicrobial formulary and restriction policy in the largest hospital in Italy. Int J Antimicrob Agents 16 (2000) 295-299
28. Ruttimann S., Keck B., Hartmaier C., Maetzel A., and Bucher C. Long term antibiotic cost savings from a comprehensive intervention program in a medical department of a university affiliated teaching hospital. Clin Infect Dis 38 (2004) 348-356
29. John J.F., and Fishman O.N. Programmatic role of the infectious diseases physician in controlling antimicrobial costs in the hospital. Clin Infect Dis 24 (1997) 471-485
30. Recco R.A., Gladstone J.L., Friedman S.A., and Gerken E.H. Antibiotic control in a municipality hospital. JAMA 241 (1979) 2283-2286
31. Sahin S.O., Ulengin F., and Ulengin B. Using neural networks and cognitive mapping in scenario analysis: the case of Turkey's inflation dynamics. EJOR 158 (2004) 124-145
32. Bergmans D.C., Bonten M.J., Gaillard C.A., van Tiel F.H., van der Geest S., de Leeuw P.W., et al. Indications for antibiotic use in ICU patients: a one year prospective surveillance. J Antimicrob Chemother 39 (1997) 527-535
33. Leblebicioglu H. Ki{dotless}si{dotless}tli{dotless} kaynaklarla infeksiyon kontrolü için organizasyonlar. In: Doganay M, Unal S, editors. Hastane İnfeksiyonlari{dotless}. 1st ed. Hastane İnfeksiyonlari{dotless} Derneǧi Yayi{dotless}ni{dotless} no: 1; 2003. p. 135-149.
34. Arda B., Yamazhan T., Tasbakan M., Pullukcu H., Sipahi O.R., and Senol S. Ege Üniversitesi Ti{dotless}p Fakültesi Hastanesi hastane enfeksiyonlari{dotless} nokta prevalans çali{dotless}şmasi{dotless}. In: Program and absracts of hastane infeksiyonlari{dotless} kongresi, hastane infeksiyonlari{dotless} derneǧi, Ankara, 2004, Abstract p54. Turk J Hosp Infect 8 Suppl. 2 (2004) 33
35. Arman D. Türkiye'de hastane infeksiyonu kontrolüne yönelik yapi{dotless}lan çali{dotless}şmalar. Turk J Hosp Infec 1 (1997) 144-152
36. Arda B., Senol S., Tasbakan M.I., Yamazhan T., Sipahi O.R., Arsu G., et al. Evaluation of compliance with hand hygiene rules in ege university intensive care units. Turk J Intens Care 5 (2005) 182-186
37. Buke C., Sipahi O., Atalay S., and Caliskan S. The knowledge and attitude regarding urinary catheters. In: program and abstracts of the 44th interscience conference on antimicrobial agents and chemotherapy (2004), American Society for Microbiology, Washington, DC, USA p. 344 [abstract K97]
38. Colak B., Etiler N., and Bicer U. Fatal occupational injuries in the construction sector in Kocaeli, Turkey, 1990-2001. Ind Health 42 (2004) 424-430